In CMS1 subtypes of CRC, there are some studies that showed the reduced expression of the EGFR ligands amphiregulin (AREG) and epiregulin (EREG), and this reduced expression is linked to hypermethylation of the ligands' promoter regions 41. This evidence concerns the gene AREG and colorectal carcinoma.